A carregar...

EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: What’s New?

In the past 10 to 15 years, a considerable progress has been made in the treatment of gastrointestinal (GI) related malignancies, as a number of agents expanded from only one in 1995 to seven in 2006. Current review describes the recent role of targeted therapies, specifically EGFR inhibitors in the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kanwar, Shailender Singh, Nautiyal, Jyoti, Majumdar, Adhip P.N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915939/
https://ncbi.nlm.nih.gov/pubmed/20298154
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!